Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
Add more filters










Publication year range
1.
Mol Biol Cell ; 28(22): 2958-2977, 2017 Nov 01.
Article in English | MEDLINE | ID: mdl-28877984

ABSTRACT

Tumors are fibrotic and characterized by abundant, remodeled, and cross-linked collagen that stiffens the extracellular matrix stroma. The stiffened collagenous stroma fosters malignant transformation of the tissue by increasing tumor cell tension to promote focal adhesion formation and potentiate growth factor receptor signaling through kinase. Importantly, collagen cross-linking requires fibronectin (FN). Fibrotic tumors contain abundant FN, and tumor cells frequently up-regulate the FN receptor α5ß1 integrin. Using transgenic and xenograft models and tunable two- and three-dimensional substrates, we show that FN-bound α5ß1 integrin promotes tension-dependent malignant transformation through engagement of the synergy site that enhances integrin adhesion force. We determined that ligation of the synergy site of FN permits tumor cells to engage a zyxin-stabilized, vinculin-linked scaffold that facilitates nucleation of phosphatidylinositol (3,4,5)-triphosphate at the plasma membrane to enhance phosphoinositide 3-kinase (PI3K)-dependent tumor cell invasion. The data explain why rigid collagen fibrils potentiate PI3K activation to promote malignancy and offer a perspective regarding the consistent up-regulation of α5ß1 integrin and FN in many tumors and their correlation with cancer aggression.


Subject(s)
Cell Adhesion/physiology , Fibronectins/metabolism , Integrin alpha5beta1/metabolism , Animals , Breast/metabolism , Cell Membrane/metabolism , Cells, Cultured , Cytokines/metabolism , Epithelial Cells/metabolism , Extracellular Matrix/metabolism , Female , Heterografts , Humans , Integrins/metabolism , Mice , Mice, Transgenic , Neoplasms/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Signal Transduction
2.
Plant Biol (Stuttg) ; 18(1): 98-103, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25865555

ABSTRACT

Sexual dimorphism in resource allocation is expected to change during the life cycle of dioecious plants because of temporal differences between the sexes in reproductive investment. Given the potential for sex-specific differences in reproductive costs, resource availability may contribute to variation in reproductive allocation in females and males. Here, we used Rumex hastatulus, a dioecious, wind-pollinated annual plant, to investigate whether sexual dimorphism varies with life-history stage and nutrient availability, and determine whether allocation patterns differ depending on reproductive commitment. To examine if the costs of reproduction varied between the sexes, reproduction was either allowed or prevented through bud removal, and biomass allocation was measured at maturity. In a second experiment to assess variation in sexual dimorphism across the life cycle, and whether this varied with resource availability, plants were grown in high and low nutrients and allocation to roots, aboveground vegetative growth and reproduction were measured at three developmental stages. Males prevented from reproducing compensated with increased above- and belowground allocation to a much larger degree than females, suggesting that male reproductive costs reduce vegetative growth. The proportional allocation to roots, reproductive structures and aboveground vegetative growth varied between the sexes and among life-cycle stages, but not with nutrient treatment. Females allocated proportionally more resources to roots than males at peak flowering, but this pattern was reversed at reproductive maturity under low-nutrient conditions. Our study illustrates the importance of temporal dynamics in sex-specific resource allocation and provides support for high male reproductive costs in wind-pollinated plants.


Subject(s)
Pollination/physiology , Rumex/physiology , Flowers/growth & development , Plant Roots/growth & development , Reproduction/physiology , Texas , Wind
3.
Oncogene ; 34(19): 2437-49, 2015 May 07.
Article in English | MEDLINE | ID: mdl-24998846

ABSTRACT

Bone morphogenetic proteins (BMPs) are secreted cytokines/growth factors that have differing roles in cancer. BMPs are overexpressed in human breast cancers, but loss of BMP signaling in mammary carcinomas can accelerate metastasis. We show that human breast cancers display active BMP signaling, which is rarely downregulated or homozygously deleted. We hypothesized that systemic inhibition of BMP signaling in both the tumor and the surrounding microenvironment could prevent tumor progression and metastasis. To test this hypothesis, we used DMH1, a BMP antagonist, in MMTV.PyVmT expressing mice. Treatment with DMH1 reduced lung metastasis and the tumors were less proliferative and more apoptotic. In the surrounding tumor microenvironment, treatment with DMH1 altered fibroblasts, lymphatic vessels and macrophages to be less tumor promoting. These results indicate that inhibition of BMP signaling may successfully target both the tumor and the surrounding microenvironment to reduce tumor burden and metastasis.


Subject(s)
Bone Morphogenetic Proteins/antagonists & inhibitors , Lung Neoplasms/prevention & control , Mammary Neoplasms, Animal/drug therapy , Pyrazoles/pharmacology , Quinolines/pharmacology , Tumor Microenvironment/drug effects , Animals , Bone Morphogenetic Proteins/metabolism , Female , Fibroblasts/drug effects , Humans , Lung Neoplasms/drug therapy , Lung Neoplasms/secondary , Lymphatic Vessels/drug effects , Lymphatic Vessels/metabolism , Macrophages/drug effects , Mammary Neoplasms, Animal/metabolism , Mice , Mice, Inbred C57BL , Mice, Transgenic , Signal Transduction/drug effects
4.
Proc Biol Sci ; 280(1750): 20122058, 2013 Jan 07.
Article in English | MEDLINE | ID: mdl-23173202

ABSTRACT

Understanding the relative importance of heterosis and outbreeding depression over multiple generations is a key question in evolutionary biology and is essential for identifying appropriate genetic sources for population and ecosystem restoration. Here we use 2455 experimental crosses between 12 population pairs of the rare perennial plant Rutidosis leptorrhynchoides (Asteraceae) to investigate the multi-generational (F(1), F(2), F(3)) fitness outcomes of inter-population hybridization. We detected no evidence of outbreeding depression, with inter-population hybrids and backcrosses showing either similar fitness or significant heterosis for fitness components across the three generations. Variation in heterosis among population pairs was best explained by characteristics of the foreign source or home population, and was greatest when the source population was large, with high genetic diversity and low inbreeding, and the home population was small and inbred. Our results indicate that the primary consideration for maximizing progeny fitness following population augmentation or restoration is the use of seed from large, genetically diverse populations.


Subject(s)
Asteraceae/genetics , Genetic Fitness , Hybrid Vigor , Hybridization, Genetic , Inbreeding , Australia , Environment , Genetic Variation , Geography , Population Density , Reproduction
5.
Heredity (Edinb) ; 100(3): 268-74, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17940547

ABSTRACT

Self-incompatibility systems function to prevent inbreeding, and work effectively in large, genetically diverse populations. However, a decrease in population size can reduce genetic diversity at the self-incompatibility locus, which leads to a reduction in mate availability and has important demographic implications for small populations. Currently, little is known about the response of self-incompatible polyploid species to a reduction in population size. In Rutidosis leptorrhynchoides there was a significant decrease in the within-population probability of fertilization with a decline in population size for diploid populations and a marginally significant relationship for tetraploid populations, suggesting that in small populations of both chromosome races fertilization success is reduced due to a decrease in self-incompatibility allele (S-allele) diversity. There was no significant difference between the slopes of the fertility-population size relationship for diploid and tetraploid populations which indicates a similar rate of decline in fertilization success with population size for both chromosome races. Fertilization success increased when crosses were undertaken between populations and this was significantly related to population size for diploid and tetraploid populations, indicating that small populations gain the greatest benefit to fertilization success from crossing between populations. For tetraploid populations the benefits of crossing between populations tended to decline more rapidly with increasing population size. These results suggest that for small populations that have reduced fertilization success, genetic rescue by introducing new genetic material from other populations is an important means of ameliorating mate limitation issues associated with reduced S-allele diversity in both diploid and tetraploid races.


Subject(s)
Asteraceae/genetics , Conservation of Natural Resources/methods , Genetics, Population , Polyploidy , Population Density , Australian Capital Territory , Fertility/genetics , Genetic Variation , Models, Genetic , New South Wales , Species Specificity
6.
J Clin Pathol ; 60(8): 856-65, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17237185

ABSTRACT

The morphologically heterogeneous (intra)ductal lesions of the prostate frequently present a diagnostic challenge, particularly when found within prostate needle biopsies. By current convention, all high-grade intra-acinar and intraductal neoplastic lesions of prostatic origin fall under the diagnostic umbrella term: prostatic intraepithelial neoplasm (PIN). Although a long-standing contentious issue, some lesions currently adhering to the diagnostic criteria of PIN may actually represent the intraductal spread of (generally high grade) invasive cancer. Illustrating this fact, the well-described ductal subtype of prostatic adenocarcinoma is frequently associated with conventional-type acinar adenocarcinoma, and has a tendency to propagate within adjacent intact prostatic ducts. Clearly, the misdiagnosis of lesions representing invasive disease as preinvasive has the potential for unfavourable clinical sequelae. As yet, however, many of these lesions have escaped the establishment of reliable morphologic criteria or immunohistochemical differentiation for diagnosis. By defining stringent architectural and cytonuclear features specific for each of these lesions, it may be feasible to separate potentially sinister lesions from the subset of traditional (preinvasive) PIN lesions with limited clinical urgency. This review discusses the (intra)ductal lesions of the prostate, along with their differential diagnoses. Given the current state of knowledge, a pragmatic approach to their effective reporting is outlined, taking into consideration the clinical implications, as well as current guidelines for treatment and follow-up.


Subject(s)
Carcinoma, Ductal/pathology , Prostate/pathology , Prostatic Neoplasms/pathology , Adenocarcinoma/pathology , Biomarkers, Tumor , Carcinoma, Acinar Cell/pathology , Diagnosis, Differential , Humans , Immunohistochemistry/methods , Male , Neoplasm Invasiveness , Prostatic Hyperplasia/pathology , Prostatic Intraepithelial Neoplasia/pathology
7.
Eur J Clin Pharmacol ; 39(6): 583-6, 1990.
Article in English | MEDLINE | ID: mdl-1982764

ABSTRACT

The effects of piroxicam (40 mg) on the pharmacokinetics of ranitidine (150 mg) and of ranitidine (150 mg bid) on the pharmacokinetics of piroxicam (20 mg) were assessed in two 2-way crossover studies in two groups of 18 healthy male subjects. In the first study there were no statistically significant differences between the pharmacokinetic variables for ranitidine in the presence or absence of piroxicam. The mean maximum plasma concentration (Cmax) was 467 ng.ml-1 for ranitidine alone and 466 ng.ml-1 in the presence of piroxicam: mean area under the plasma concentration vs time curve (AUC) was 2460 h.ng ml-1 and 2551 h.ng ml-1 respectively; and the mean terminal half-life (t 1/2) was 3.6 h and 3.8 h respectively. In the second study there were no statistically significant differences between the pharmacokinetic variables for piroxicam in the presence or absence of ranitidine. The mean Cmax was 2.1 micrograms.ml-1 in the presence of placebo and 2.0 micrograms.ml-1 in the presence of ranitidine respectively; mean AUC was 133 h.microgram ml-1 and 137 h.microgram ml-1 respectively, and the mean t 1/2 was 53.6 h and 54.5 h respectively.


Subject(s)
Piroxicam/pharmacokinetics , Ranitidine/pharmacokinetics , Adolescent , Adult , Double-Blind Method , Drug Interactions , Histamine H2 Antagonists/administration & dosage , Histamine H2 Antagonists/pharmacokinetics , Histamine H2 Antagonists/pharmacology , Humans , Male , Middle Aged , Piroxicam/administration & dosage , Piroxicam/pharmacology , Ranitidine/administration & dosage , Ranitidine/pharmacology
10.
Scand J Rheumatol ; 13(1): 39-44, 1984.
Article in English | MEDLINE | ID: mdl-6202005

ABSTRACT

C-reactive protein (CRP) levels were measured in 105 patients with rheumatoid arthritis (RA) during treatment with slow-acting anti-rheumatoid drugs D-penicillamine, alclofenac, hydroxychloroquine, gold, sulphasalazine and azathioprine. A control group treated with aspirin alone was also included. Patients were assessed clinically (pain score, articular index and summated change score) and in terms of acute-phase reactants (CRP, haptoglobin, fibrinogen, ESR and plasma viscosity) at eight separate clinic visits during the 6-month treatment period. The estimation of CRP was found to be more useful than haptoglobin, fibrinogen or ESR as an index of disease activity.


Subject(s)
Arthritis, Rheumatoid/diagnosis , C-Reactive Protein/analysis , Acute-Phase Proteins , Adult , Aged , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/physiopathology , Blood Proteins/analysis , Female , Humans , Male , Middle Aged
11.
Agents Actions ; 13(4): 373-9, 1983 Jun.
Article in English | MEDLINE | ID: mdl-6613752

ABSTRACT

In a long-term study we have been comparing biochemical changes in the blood of patients with classical or definite rheumatoid arthritis (RA) when groups of patients are treated for the first time with specific anti-rheumatoid drugs for a six-month period. One such group was treated for 26 weeks with azathioprine. Biochemical and clinical assessments were made at each of 10 clinic visits during the treatment period. Side-effects prevented six patients completing the study. Clinical improvement in the remaining patients was accompanied by a reduction in acute phase proteins, increases in total serum sulphydryl and serum histidine, but little or no change in immunological variables. Comparison of correlation matrices constructed between clinical and laboratory variables for azathioprine and drugs previously tested suggests that azathioprine is more effective than a control group on aspirin alone and in some ways comparable with D-penicillamine.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Azathioprine/therapeutic use , Aged , Antibodies/analysis , Arthritis, Rheumatoid/blood , Arthritis, Rheumatoid/enzymology , Blood Viscosity/drug effects , Female , Histidine/blood , Humans , Male , Middle Aged , Platelet Count , Sulfhydryl Compounds/blood , Time Factors
12.
Clin Exp Rheumatol ; 1(2): 93-9, 1983.
Article in English | MEDLINE | ID: mdl-6398158

ABSTRACT

We have compared two dose levels of Clozic, a novel agent with potential anti-rheumatoid activity, to D-penicillamine and aspirin in an observer blind randomised parallel group study of 56 patients with active rheumatoid arthritis. Eight clinical assessments and 26 laboratory assessments were performed on each patient at each visit over a six month period. Results were analysed by conventional methods and also by correlation matrices constructed between clinical and laboratory variables. Patients treated with D-penicillamine (500 mg/day) responded adequately and the control group on aspirin (up to 3.6 g of enteric coated formulation/day) performed well, though the withdrawal rate from this latter group was high, predominantly because of continued disease activity. Patients receiving Clozic (100 mg/day or 300 mg/day) improved more than patients receiving penicillamine, particularly at the higher dose. Comparison of methods of analysis validates the use of correlation matrices both for detecting anti-rheumatoid activity and for determining the optimum dose of a novel compound. This trial illustrates the problems of a study of this nature, with the powerful effect on patients of being enrolled in such a closely monitored investigation. It emphasises the greater value of biochemical changes in following disease changes.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Clofibrate/analogs & derivatives , Arthritis, Rheumatoid/metabolism , Aspirin/adverse effects , Aspirin/therapeutic use , Clinical Trials as Topic , Clofibrate/adverse effects , Clofibrate/therapeutic use , Dose-Response Relationship, Drug , Female , Humans , Male , Middle Aged , Penicillamine/adverse effects , Penicillamine/therapeutic use , Tablets, Enteric-Coated , Time Factors
13.
Curr Med Res Opin ; 8(6): 412-6, 1983.
Article in English | MEDLINE | ID: mdl-6342955

ABSTRACT

An open crossover study was carried out in 8 normal volunteer subjects to compare faecal blood loss resulting from tilcotil (Ro12-0068), a new anti-inflammatory agent, and from enteric-coated aspirin. After a 1-week run-in period, subjects were allocated at random to receive treatment for 2 weeks with either 40 mg tilcotil as a single dose per day or aspirin, 900 mg 4-times daily, reduced if necessary to a maximum tolerated dose. Subjects were then crossed over to the alternative treatment for a further 2 weeks. The results showed that tilcotil produced less blood loss, assessed by a radioactive labelling method, and was better tolerated than aspirin. Plasma concentrations of tilcotil showed that the drug's half-life was approximately 50 hours, compatible with once daily dosage, and steady state concentrations on multiple dosing were reached after 10 to 12 days.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Aspirin/administration & dosage , Gastrointestinal Hemorrhage/chemically induced , Piroxicam/analogs & derivatives , Thiazines/administration & dosage , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Clinical Trials as Topic , Dose-Response Relationship, Drug , Female , Humans , Kinetics , Male , Middle Aged , Random Allocation , Thiazines/adverse effects , Thiazines/blood
14.
Rheumatol Int ; 3(4): 145-9, 1983.
Article in English | MEDLINE | ID: mdl-6366988

ABSTRACT

Groups of 15 patients with active rheumatoid arthritis were treated for 24 weeks with zinc sulphate, trien, captopril, clozic in two doses or a combination of D-penicillamine and hydroxychloroquine. Serum histidine levels were monitored along with measures of disease activity including C-reactive protein, plasma viscosity, articular index, grip strength and early morning stiffness. Zinc sulphate and trien were found to be ineffective while the other drugs all showed evidence of second-line action. Serum histidine was found to improve during successful therapy. The possible cause of low serum histidine and its response to therapy is discussed.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Histidine/blood , Arthritis, Rheumatoid/blood , Captopril/therapeutic use , Clofibrate/analogs & derivatives , Clofibrate/therapeutic use , Drug Combinations , Female , Humans , Hydroxychloroquine/therapeutic use , Male , Middle Aged , Penicillamine/therapeutic use , Sulfates/therapeutic use , Trientine/therapeutic use , Zinc/therapeutic use , Zinc Sulfate
16.
Eur J Clin Pharmacol ; 23(4): 321-5, 1982 Oct.
Article in English | MEDLINE | ID: mdl-7173301

ABSTRACT

1. Two oral corticosteroids, prednisolone (8 mg/day) and betamethasone (1 mg/day) have been compared in terms of efficacy and adrenal suppressive activity when used in chronic oral dosage in rheumatoid arthritis. 2. 20 patients were entered to a single blind crossover study receiving each drug for a two-week period. Clinical and laboratory assessments were performed. 3. At this dosage there was no significant difference between any of the clinical parameters assessed for either drug though patient preference was 13 for prednisolone and 7 for betamethasone. 4. At this dosage adrenal suppression was not equivalent, being significantly more marked with betamethasone. 5. The results suggest that prednisolone is the drug of choice for chronic dosage.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Betamethasone/therapeutic use , Prednisolone/therapeutic use , Adult , Aged , Betamethasone/adverse effects , Diarrhea/chemically induced , Dizziness/chemically induced , Drug Evaluation , Humans , Isometric Contraction , Middle Aged , Prednisolone/adverse effects , Random Allocation , Sleep Stages/drug effects
17.
Clin Chim Acta ; 124(1): 23-9, 1982 Sep 01.
Article in English | MEDLINE | ID: mdl-7127837

ABSTRACT

An inexpensive gas chromatographic method is described that allows simultaneous measurement in urine of androsterone (A), aetiocholanolone (E), 11-hydroxyandrosterone (11-OA), 11-hydroxyaetiocholanolone (11-OE), pregnanediol (PD), pregnanetriol (PT), tetrahydrocortisone (THE) and tetrahydrocortisol (THF). Dehydroepiandrosterone was also resolved by the column. Ibuprofen was administered to five healthy normal males at a dose used therapeutically in rheumatoid arthritis (RA). The above urinary steroids were measured weekly during a control period, during a four week period of drug treatment and for four weeks after drug treatment had ceased. The excretion of A fell to a mean of 63% of the control value (p less than 0.02) and returned to the control value within two weeks. 11-OA, which showed a greater variability than A, fell to the same extent (p less than 0.1). No other steroid measured showed a change that could be related to the drug. This relatively limited effect of ibuprofen on steroid metabolism makes it a suitable drug for maintaining patients with RA during studies of their steroid metabolism.


Subject(s)
Ibuprofen/pharmacology , Steroids/urine , Adult , Androsterone/analogs & derivatives , Androsterone/urine , Chromatography, Gas , Etiocholanolone/urine , Humans , Male , Middle Aged , Tetrahydrocortisol/urine , Tetrahydrocortisone/urine
18.
Curr Med Res Opin ; 8(1): 9-13, 1982.
Article in English | MEDLINE | ID: mdl-6980774

ABSTRACT

An open crossover study was carried out in 6 normal volunteers to measure faecal blood loss caused by tilcotil (Ro 12-0068), a new anti-inflammatory drug, compared with that caused by enteric-coated aspirin. Subjects were allocated at random to receive either single doses of 20 mg tilcotil daily or 900 mg aspirin 4-times daily, reducing to a maximum tolerated dose, over a period of 2 weeks before being crossed over to the alternative medication for a further 2 weeks. Faecal specimens passed during 4 consecutive days in a run-in-period of 1 week, in each treatment period, and in the 2 weeks after the finish of drug therapy were analyzed for blood using a radioactive labelling method. The results showed that faecal blood loss was lower and it did not produce any haematological or biochemical abnormalities or any increase in urinary N-acetyl-beta-glucosaminidase activity indicative of renal damage. It is suggested that the method described provides a simple and reliable means of comparing faecal blood loss with different anti-inflammatory drugs.


Subject(s)
Anti-Inflammatory Agents/adverse effects , Aspirin/adverse effects , Gastrointestinal Hemorrhage/chemically induced , Piroxicam/analogs & derivatives , Thiazines/adverse effects , Acetylglucosaminidase/urine , Adult , Female , Humans , Kidney/drug effects , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...